Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: capitalistbeatnik who wrote (1375)	11/8/1999 12:41:00 PM
From: Angler	Read Replies (2) \| Respond to of 1754

True. However, VISX is really on the defensive here suing against challenges and counter claims to at least two of their most critical patents. The cases initiated by their own suits against Nidek Co. are international in scope ranging from Canada to France. Besides this there are several federal anti trust class action suits vs VISX unresolved in various U.S. courts. Outcomes are yet unknown. VISX has stated that any "adverse determination" could limit their ability to collect license fees. The patent litigation is probably the most worrisome. I'm optimistic long run but nevertheless the officers have sold off a lot of shares. Is it better safe than sorry? Angler